Literature DB >> 31486505

Influences of miR-155/NF-κB signaling pathway on inflammatory factors in ARDS in neonatal pigs.

Z-Q Liu1, J Feng, L-L Shi, J Xu, B-J Zhang, L-J Chen.   

Abstract

OBJECTIVE: Acute respiratory distress syndrome (ARDS) is greatly threatening human health with high morbidity and mortality. The pathogenesis of ARDS is closely related to the inflammatory response in patients. The micro-ribonucleic acid (miR)-155/nuclear factor-κB (NF-κB) signaling pathway is crucial in regulating the expression of inflammation-related genes. Therefore, the influences of miR-155/NF-κB signaling pathway on inflammatory factors in ARDS in neonatal pigs were explored in this study.
MATERIALS AND METHODS: The model of ARDS in neonatal pigs was established first. The expression levels of miR-155, NF-κB-related proteins, and inflammatory factors in model group and control group were detected, and their differences were compared. Moreover, after treatment with the miR-155/NF-κB signaling pathway inhibitor, the changes of the inflammatory factors expression in ARDS neonatal pigs were observed at different time points.
RESULTS: In the model group, the levels of miR-155 and NF-κB-related proteins were significantly increased, and the levels of inflammatory factors, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and IL-6, were also increased synchronously. However, the levels of IL-4 and IL-10 declined significantly. In addition, it was proved that after treatment with the inhibitor in model group the mRNA expressions of miR-155/NF-κB signaling pathway-related proteins were significantly inhibited, and the levels of IL-1β, TNF-α, and IL-6 were also significantly inhibited (p<0.05). The levels of IL-4 and IL-10 remarkably rose after treatment with the inhibitor for 24 h (p<0.05).
CONCLUSIONS: The miR-155/NF-κB signaling pathway influenced the changes of inflammatory factors in ARDS in neonatal pigs, which might be a potential target for eliminating the inflammatory response after ARDS in neonatal pigs.

Entities:  

Year:  2019        PMID: 31486505     DOI: 10.26355/eurrev_201908_18746

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection.

Authors:  Riham Abdel-Hamid Haroun; Waleed H Osman; Rasha E Amin; Ahmad K Hassan; Waleed S Abo-Shanab; Asmaa M Eessa
Journal:  Pathology       Date:  2021-11-06       Impact factor: 5.306

2.  Lipocalin-2 silencing suppresses inflammation and oxidative stress of acute respiratory distress syndrome by ferroptosis via inhibition of MAPK/ERK pathway in neonatal mice.

Authors:  Xiaodong Wang; Chunhua Zhang; Na Zou; Qinghua Chen; Chaojun Wang; Xu Zhou; Li Luo; Haibin Qi; Junhua Li; Zhiyan Liu; Jinghong Yi; Jing Li; Wei Liu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 3.  miR-155: An Important Role in Inflammation Response.

Authors:  Jingyan Hu; Songli Huang; Xiaoli Liu; Yuan Zhang; Shengli Wei; Xiuhua Hu
Journal:  J Immunol Res       Date:  2022-04-06       Impact factor: 4.818

4.  Interleukin-37 Attenuates Lipopolysaccharide (LPS)-Induced Neonatal Acute Respiratory Distress Syndrome in Young Mice via Inhibition of Inflammation and Cell Apoptosis.

Authors:  Bo Li; Xianqiu Ji; Fang Tian; Jingjing Gong; Jie Zhang; Ting Liu
Journal:  Med Sci Monit       Date:  2020-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.